Premium
Intraperitoneal bupivacaine for analgesia after laparoscopic cholecystectomy
Author(s) -
MRAOVIČ B.,
JURIŠIČ T.,
KOGLERMAJERIC V.,
SUSTIC A.
Publication year - 1997
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/j.1399-6576.1997.tb04664.x
Subject(s) - medicine , bupivacaine , laparoscopic cholecystectomy , anesthesia , cholecystectomy , surgery , general surgery
Background The effects of intraperitoneal administration of bupivacaine on pain after laparoscopic cholecystectomy were studied in a prospective, double‐blind, randomised trial. Methods: Eighty ASA 1 and 2 patients were randomly assigned to one of two groups. Immediately after pneumoperi‐toneum was obtained patients in group 1 were given 15 ml of 0.5% bupivacaine injected under direct vision into the hepato‐diaphragmatic space, near and above the hepato‐duodenal ligament and above the gallbladder. At the end of operation another 15 ml of bupivacaine was injected. Patients in group 2 were given 15 ml of 0.9% saline solution in a similar fashion. Postoperative pain was assessed using a visual analogue scale (VAS 100 mm) at 0.5,4, 8,12 and 24 h after surgery. Analgesic consumption was also recorded.